Laboratory Equipment Market Size, Share, Regional Growth, 2026-2034
- jhon smith
- 6 days ago
- 4 min read
Market OverviewAccording to fortune business insights, The global laboratory equipment market size was valued at USD 20.5 billion in 2025. The market is projected to grow from USD 23.28 billion in 2026 to USD 64.43 billion by 2034, exhibiting a CAGR of 13.57% during the forecast period. North America dominated the laboratory equipment market as the leading segment in 2025.
The analysis shows that top companies are investing more in laboratory equipment because of rising R&D investments, rapid technological advancements, and ubiquitous diagnostic testing. For example, according to the National Institutes of Health (NIH), the U.S. has over 50,000 laboratories using advanced laboratory equipment. This trend indicates a strong demand for high-precision instruments for research, diagnostics, and quality control worldwide.
Major Players Profiled in the Market Report:
Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
Merck KGaA (Darmstadt, Germany)
Agilent Technologies, Inc. (California, U.S.)
Sartorius AG (Göttingen, Germany)
Bio-Rad Laboratories, Inc. (California, U.S.)
Bruker Corporation (Massachusetts, U.S.)
Shimadzu Corporation (Kyoto, Japan)
Eppendorf SE (Hamburg, Germany)
MRC Group (Holon, Israel)
SegmentsHigh Demand for Precision Testing to Propel Analytical Equipment Segment GrowthBased on type, the market is divided into analytical equipment, measuring equipment, heating & cooling equipment, and others. The analytical equipment segment holds the largest market share and dominates the market owing to the growing need for accurate chemical and biological analyses in the pharmaceutical, food, and environmental industries, driven by advancements in precision testing and automation.
Rising Research on Infectious Diseases to Drive Microbiology Segment ExpansionBy application, the market is categorized into microbiology, biochemistry, endocrinology, and others. The microbiology segment is leading the market as there is high demand for advanced equipment for pathogen identification, antimicrobial resistance detection, and clinical diagnostics, fueled by increasing research on infectious diseases and biotechnology.
Massive R&D Investments to Drive Pharma & Biotech Segment DominanceBased on end user, the market is segmented into pharmaceutical & biotechnology companies, diagnostic centers, healthcare facilities, and others. The pharmaceutical & biotechnology companies segment holds the largest market share owing to massive R&D investments in new therapies, biological innovations, and precision medicine, which require advanced laboratory equipment to ensure research efficiency and accuracy.
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Report CoverageThe report offers:
Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
Comprehensive insights into regional developments.
List of major industry players.
Key strategies adopted by the market players.
The latest industry developments include product launches, partnerships, mergers, and acquisitions.
Drivers & RestraintsIncreasing R&D Investments to Propel Market GrowthThe rapid growth in R&D investments from pharmaceutical companies, biotechnology firms, and academic institutions has raised the demand for advanced laboratory equipment. This spending is crucial for precise experimentation, drug discovery, and scientific innovation, boosting the laboratory equipment market growth.
However, the high cost of advanced laboratory equipment may hamper market growth. Many smaller laboratories and institutions face budget constraints, which restricts their access to high-precision instruments and can impact their research and diagnostic standards.
Regional InsightsHeavy R&D Investment in the U.S. Propels Market Growth in North AmericaNorth America holds the dominant laboratory equipment market share and is projected to experience strong growth during the forecast period. The region’s growth is attributed to heavy investments in research, a highly developed healthcare infrastructure, and strong government support for scientific innovation, which drives high demand for diagnostic tests and advanced technologies.
Asia Pacific is one of the fastest-growing regions in the market. The growth is attributed to rapid industrialization, increasing government and private investment in research, and improving healthcare infrastructure in developing nations, including China and India.
Laboratory Equipment Market Future Growth:The laboratory equipment market is experiencing robust growth, fueled by rising R&D spending, the growing trend of automation and AI integration, and a strong shift toward personalized medicine. Today's laboratories are increasingly drawn to equipment that offers higher efficiency, accuracy, and productivity—favoring automated systems that minimize human error and support high-throughput analysis. Additionally, there's a growing interest in eco-friendly equipment and specialized instruments for genomics and biobanking. The rapid expansion of diagnostic testing in emerging markets is also a key growth driver. While North America continues to dominate due to massive R&D investment, the Asia-Pacific region is seeing a surge in demand, driven by industrialization and improving healthcare infrastructure.
Competitive LandscapeGrowing Adoption of New Product Lines to Propel Market GrowthThe market features prominent players like Thermo Fisher Scientific, Merck KGaA, and others. These leading companies are accelerating growth through strategic initiatives such as launching dynamic new product lines, developing automated and AI-integrated systems, and forming partnerships with research institutions. Their proactive approach to innovation and addressing the evolving needs of various industries continues to fuel the market’s momentum.
Key Industry Development
January 2025: Dynarex Corporation launched LabChoice, a new line of laboratory products designed to meet the precision tool requirements of research, healthcare, education, and food & beverage industries.
October 2024: Thermo Fisher Scientific Inc. announced a new AI-integrated analytical platform designed to streamline workflows and enhance data accuracy for complex research applications, accelerating drug discovery timelines.
Comments